Sign in
Unexpected High Lung Toxicity from Radiation Pneumonitis in a Phase I/II Trial of Concurrent Erlotinib with Limited Field Radiation for Intermediate Prognosis Patients with Stage III or Inoperable Stage IIB Non–small-cell Lung Cancer(NSCLC)
Journal article

Unexpected High Lung Toxicity from Radiation Pneumonitis in a Phase I/II Trial of Concurrent Erlotinib with Limited Field Radiation for Intermediate Prognosis Patients with Stage III or Inoperable Stage IIB Non–small-cell Lung Cancer(NSCLC)

J Wan, V Cohen, J Agulnik, S Faria, L Portelance, L Ofiara, K Sultanem, L Souhami and V Hirsh
International journal of radiation oncology, biology, physics, Vol.75(3), pp.S110-S110
2009

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.199 Lung Cancer
1.199.581 NSCLC
Web Of Science research areas
Oncology
Radiology, Nuclear Medicine & Medical Imaging
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details